Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3657694 | 0.81 | HTT (0.59) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL3658650 | 0.80 | HTT (0.62) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL9450633 | 0.80 | HTT (0.58) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL8095290 | 0.77 | HTT (0.52) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL14973545 | 0.76 | KMT2A (0.60) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL864222 | 0.76 | HTT (0.54) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL14994325 | 0.75 | KMT2A (0.51) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL9450597 | 0.75 | KMT2A (0.55) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL9450600 | 0.75 | KMT2A (0.55) | ALDH1A1KDM4ETDP1HPGDLMNA | |
| SCHEMBL9450601 | 0.75 | KMT2A (0.55) | ALDH1A1KDM4ETDP1HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | ALDH1A1 2164/4885KDM4E 2541/4885TDP1 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.